{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ALRN",
        "Security_Name": "Aileron Therapeutics, Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "S",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "D",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ALRN",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 4,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 1,
                "buy": 0,
                "hold": 3,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 1,
                "buy": 0,
                "hold": 3,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 4,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 2.55,
        "open": 2.575,
        "dayLow": 2.55,
        "dayHigh": 2.69,
        "regularMarketPreviousClose": 2.55,
        "regularMarketOpen": 2.575,
        "regularMarketDayLow": 2.55,
        "regularMarketDayHigh": 2.69,
        "payoutRatio": 0,
        "beta": 2.037214,
        "forwardPE": -6.7179484,
        "volume": 12674,
        "regularMarketVolume": 12674,
        "averageVolume": 31595,
        "averageVolume10days": 76030,
        "averageDailyVolume10Day": 76030,
        "bid": 2.08,
        "ask": 2.66,
        "bidSize": 1000,
        "askSize": 2900,
        "marketCap": 237302816,
        "fiftyTwoWeekLow": 1.79,
        "fiftyTwoWeekHigh": 15,
        "fiftyDayAverage": 2.98708,
        "twoHundredDayAverage": 5.66367,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2021",
                    "actual": -0.07,
                    "estimate": -0.07
                },
                {
                    "date": "4Q2021",
                    "actual": -0.08,
                    "estimate": -0.08
                },
                {
                    "date": "1Q2022",
                    "actual": -0.09,
                    "estimate": -0.08
                },
                {
                    "date": "2Q2022",
                    "actual": -0.09,
                    "estimate": -0.09
                }
            ],
            "currentQuarterEstimate": -0.08,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1679875200,
                1680220800
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 0,
                    "earnings": -31547000
                },
                {
                    "date": 2019,
                    "revenue": 0,
                    "earnings": -29369000
                },
                {
                    "date": 2020,
                    "revenue": 0,
                    "earnings": -21157000
                },
                {
                    "date": 2021,
                    "revenue": 0,
                    "earnings": -26164000
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 0,
                    "earnings": -6704000
                },
                {
                    "date": "4Q2021",
                    "revenue": 0,
                    "earnings": -6799000
                },
                {
                    "date": "1Q2022",
                    "revenue": 0,
                    "earnings": -8422000
                },
                {
                    "date": "2Q2022",
                    "revenue": 0,
                    "earnings": -7992000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1679875200,
                1680220800
            ],
            "earningsAverage": -0.08,
            "earningsLow": -0.09,
            "earningsHigh": -0.07
        }
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-06-30T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-06-29T00:00:00.000Z",
                "firm": "William Blair",
                "toGrade": "Market Perform",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2020-06-05T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-03-31T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-04-09T00:00:00.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Buy",
                "fromGrade": "Buy",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-03-11T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-07-24T00:00:00.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-07-24T00:00:00.000Z",
                "firm": "B of A Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-07-24T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "DELAYED",
        "postMarketChangePercent": -0.087786175,
        "postMarketChange": -0.22999978,
        "postMarketTime": "2023-01-06T23:56:04.000Z",
        "postMarketPrice": 2.39,
        "postMarketSource": "DELAYED",
        "regularMarketChangePercent": 0.027450955,
        "regularMarketChange": 0.06999993,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 4,
        "regularMarketPrice": 2.62,
        "regularMarketDayHigh": 2.69,
        "regularMarketDayLow": 2.55,
        "regularMarketVolume": 12674,
        "averageDailyVolume10Day": 76030,
        "averageDailyVolume3Month": 31595,
        "regularMarketPreviousClose": 2.55,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 2.575,
        "exchange": "NCM",
        "exchangeName": "NasdaqCM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ALRN",
        "underlyingSymbol": null,
        "shortName": "Aileron Therapeutics, Inc.",
        "longName": "Aileron Therapeutics, Inc.",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 237302816
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": -13654080,
        "forwardPE": -9.703703,
        "profitMargins": 0,
        "floatShares": 58497662,
        "sharesOutstanding": 90573600,
        "sharesShort": 258869,
        "sharesShortPriorMonth": 63271,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.0028,
        "heldPercentInsiders": 0.090220004,
        "heldPercentInstitutions": 0.3549,
        "shortRatio": 0.17,
        "shortPercentOfFloat": 0.0036000002,
        "beta": 2.037214,
        "category": null,
        "bookValue": 0.278,
        "priceToBook": 9.42446,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -29917000,
        "trailingEps": -0.607,
        "forwardEps": -0.39,
        "pegRatio": -0.29,
        "lastSplitFactor": null,
        "enterpriseToEbitda": 0.457
    },
    "summaryProfile": {
        "address1": "285 Summer Street",
        "address2": "Suite 101",
        "city": "Boston",
        "state": "MA",
        "zip": "02210",
        "country": "United States",
        "phone": "617 995 0900",
        "fax": "617 995 2410",
        "website": "https://www.aileronrx.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. It has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts.",
        "fullTimeEmployees": 9,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 2.62,
        "targetHighPrice": 2,
        "targetLowPrice": 2,
        "targetMeanPrice": 2,
        "targetMedianPrice": 2,
        "recommendationMean": 2.5,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 1,
        "totalCash": 32382000,
        "totalCashPerShare": 0.357,
        "ebitda": -29907000,
        "totalDebt": 100000,
        "quickRatio": 6.287,
        "currentRatio": 6.513,
        "debtToEquity": 0.349,
        "returnOnAssets": -0.39858,
        "returnOnEquity": -0.70601,
        "grossProfits": -17008000,
        "freeCashflow": -15776125,
        "operatingCashflow": -27000000,
        "grossMargins": 0,
        "ebitdaMargins": 0,
        "operatingMargins": 0,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}